Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: Early disagreements and low utilization

Journal of General Internal Medicine

Volumn 24, Issue 7, 2009, Pages 822-828

  Levy, Douglas E ^a   Garber, Judy E ^b,c   Shields, Alexandra E ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

BRCA1 2 testing; Breast cancer; Genetic risk assessment; Guidelines; Hereditary; Ovarian cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; BREAST CANCER; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; GENETIC RISK; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRACTICE GUIDELINE; RISK ASSESSMENT; SELF REPORT; ADOLESCENT; BREAST NEOPLASMS; CONFIDENCE INTERVAL; GENETIC SCREENING; GENETICS; GERIATRIC ASSESSMENT; MIDDLE AGED; OVARIAN NEOPLASMS; RISK; TIME; TUMOR SUPPRESSOR GENE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CONFIDENCE INTERVALS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC TESTING; GERIATRIC ASSESSMENT; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; RISK; RISK ASSESSMENT; TIME FACTORS; YOUNG ADULT;

EID: 67649429208     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-009-1009-6     Document Type: Article

References (47)

1. American Society of Clinical Oncology 2003 American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility J Clin Oncol 21 12 2397 406
2. National Comprehensive Cancer Network. Genetic/Familial High-Risk Assessment: Breast and Ovarian V.1.2007. Fort Washington, PA; 2007.
3. US Preventive Services Taskforce 2005 Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement Ann Intern Med 143 5 355 61
4. Myriad Genetics. Myriad Genetics Awarded Three US Patents And Eight International Patents. Salt Lake City, UT; 2001:News release.
5. JE Garber K Offit 2005 Hereditary cancer predisposition syndromes J Clin Oncol 23 2 276 92
6. J Prat A Ribe A Gallardo 2005 Hereditary ovarian cancer Hum Pathol 36 8 861 70
7. American Cancer Society. Leading sites of new cancer cases and deaths-2008 estimates.; 2008.
8. HD Nelson LH Huffman R Fu EL Harris 2005 Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the US Preventive Services Task Force Ann Intern Med 143 5 362 79
9. A Antoniou PD Pharoah S Narod 2003 Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 5 1117 30
10. SM Domchek TM Friebel SL Neuhausen 2006 Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study Lancet Oncol 7 3 223 9
11. D Abeliovich L Kaduri I Lerer 1997 The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women Am J Hum Genet 60 3 505 14
12. TS Frank AM Deffenbaugh JE Reid 2002 Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals J Clin Oncol 20 6 1480 90
13. American Society of Clinical Oncology 1996 Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996 J Clin Oncol 14 5 1730 6 discussion 1737-40
14. M Daly 1999 NCCN Practice Guidelines: Genetics/Familial High-Risk Cancer Screening Oncology 13 11A 161 183
15. American College of Medical Genetics Foundation. Genetic Susceptibility to Breast and Ovarian Cancer: Assessment, Counseling and Testing Guidelines. 1999.
16. TC Rosenthal SM Puck 1999 Screening for genetic risk of breast cancer Am Fam Physician 59 1 99 104 106 (Pubitemid 29031653)
17. Birkhead GS. Letter to physicians: Genetic Testing for BRCA1 and BRCA2: Information for Health Care Professionals, NYS Dept. of Health, Center for Community Health, August 22, 2007.
18. G Zou 2004 A modified poisson regression approach to prospective studies with binary data Am J Epidemiol 159 7 702 6
19. McClain MR, Palomaki GE, Hampel H, Westman JA, Haddow JE. Screen positive rates among six family history screening protocols for breast/ovarian cancer in four cohorts of women. Fam Cancer. 2008.
20. L Scheuer N Kauff M Robson 2002 Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers J Clin Oncol 20 5 1260 8
21. MD Cabana CS Rand NR Powe 1999 Why don't physicians follow clinical practice guidelines? A framework for improvement Jama 282 15 1458 65
22. J Mouchawar K Valentine Goins C Somkin 2003 Guidelines for breast and ovarian cancer genetic counseling referral: adoption and implementation in HMOs Genet Med 5 6 444 50
23. AE Shields D Blumenthal KB Weiss CB Comstock D Currivan C Lerman 2005 Barriers to translating emerging genetic research on smoking into clinical practice. Perspectives of primary care physicians J Gen Intern Med 20 2 131 8
24. S Suther P Goodson 2003 Barriers to the provision of genetic services by primary care physicians: a systematic review of the literature Genet Med 5 2 70 6
25. L Wideroff ST Vadaparampil MH Greene S Taplin L Olson AN Freedman 2005 Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians J Med Genet 42 10 749 55
26. SA Sabatino EP McCarthy RS Phillips RB Burns 2007 Breast cancer risk assessment and management in primary care: provider attitudes, practices, and barriers Cancer Detect Prev 31 5 375 83
27. US task force clarifies who should be screened for BRCA mutations. Reuters Health Medical News 2005 September 6, 2005.
28. Bristol N. High-Risk Testing. The Washington Post 2005 September 27, 2005;F02.
29. McCullough M. Breast cancer tests get new guidelines. Philadelphia Inquirer 2005 September 7, 2005;A03.
30. Rubin R. Genetic predisposition is reason to screen, new guidelines say. USA Today 2005 September 6, 2005;7D.
31. D Mechanic DD McAlpine M Rosenthal 2001 Are patients' office visits with physicians getting shorter? N Engl J Med 344 3 198 204 (Pubitemid 32065738)
32. W Burke 2005 Taking family history seriously Ann Intern Med 143 5 388 9
33. Blumenthal D. Stimulating the Adoption of Health Information Technology. N Engl J Med. 2009.
34. B Chaudhry J Wang S Wu 2006 Systematic review: impact of health information technology on quality, efficiency, and costs of medical care Ann Intern Med 144 10 742 52
35. C DesRoches E Campbell S Rao 2008 Electronic health records in ambulatory care - a national survey of physicians N Engl J Med 359 50 60 (Pubitemid 351931096)
36. J Emery R Walton M Murphy 2000 Computer support for interpreting family histories of breast and ovarian cancer in primary care: comparative study with simulated cases Bmj 321 7252 28 32 (Pubitemid 30417024)
37. K Kawamoto CA Houlihan EA Balas DF Lobach 2005 Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success Bmj 330 7494 765
38. Qureshi N, Wilson B, Santaguida P, et al. Collection and use of cancer family history in primary care. Evid Rep Technol Assess (Full Rep). 2007;(159):1-84.
39. K Armstrong E Micco A Carney J Stopfer M Putt 2005 Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer Jama 293 14 1729 36
40. K Gwyn SW Vernon PM Conoley 2003 Intention to pursue genetic testing for breast cancer among women due for screening mammography Cancer Epidemiol Biomarkers Prev 12 2 96 102 (Pubitemid 36193998)
41. K Armstrong J Weiner B Weber DA Asch 2003 Early adoption of BRCA1/2 testing: who and why Genet Med 5 2 92 8
42. HS Thompson HB Valdimarsdottir C Duteau-Buck 2002 Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women Cancer Epidemiol Biomarkers Prev 11 12 1579 85
43. MA Hall JE McEwen JC Barton 2005 Concerns in a primary care population about genetic discrimination by insurers Genet Med 7 5 311 6
44. C Lerman C Hughes SJ Lemon 1998 What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing J Clin Oncol 16 5 1650 4
45. CM Velicer S Taplin 2001 Genetic testing for breast cancer: where are health care providers in the decision process? Genet Med 3 2 112 9
46. Johnson A. Genetic privacy. Genetics Brief. 2002(4).
47. WF Mulholland AS Jaeger 1999 Genetic privacy and discrimination: a survey of state legislation Comment. Jurimetrics 39 3 317 26